ADVFN US – Market Content Editor

  • Plus Therapeutics Shares Surge After UnitedHealthcare Coverage Deal

    Plus Therapeutics Shares Surge After UnitedHealthcare Coverage Deal

    Plus Therapeutics Inc. (NASDAQ:PSTV) jumped 60% in premarket trading Thursday following news of a national agreement with UnitedHealthcare Insurance Company (NYSE:UNH) covering its CNSide® Cerebrospinal Fluid Tumor Cell Enumeration test. The agreement, effective September 15, 2025, provides coverage for more than 51 million people across the United States. The test is available through CNSide Diagnostics,…

  • SciSparc Shares Surge Following Launch of Quantum Computing Program

    SciSparc Shares Surge Following Launch of Quantum Computing Program

    SciSparc Ltd. (NASDAQ:SPRC) jumped 45.5% in premarket trading Thursday after announcing a new quantum computing initiative focused on 3D protein modeling. The clinical-stage pharmaceutical company, specializing in therapies for central nervous system disorders, revealed that its board has approved a program designed to revolutionize drug discovery using quantum computing technology. The project aims to enhance…

  • Safe & Green Shares Surge Following Settlement With EDI/PVE

    Safe & Green Shares Surge Following Settlement With EDI/PVE

    Safe & Green Holdings Corp. (NASDAQ:SGBX) saw its stock rise 10.5% in premarket trading Thursday after announcing a settlement that resolves all pending litigation with EDI International, PC and PVE, LLC. The company’s subsidiary, SG Blocks, Inc., finalized the settlement with EDI/PVE on September 11, 2025, under which EDI/PVE will pay SG Blocks an undisclosed…

  • MBX Biosciences Shares Drop Following Upsized Public Offering Pricing

    MBX Biosciences Shares Drop Following Upsized Public Offering Pricing

    MBX Biosciences Inc (NASDAQ:MBX) saw its stock decline 7% in premarket trading Thursday after the clinical-stage biotech firm announced the pricing of its expanded public offering. The company, which develops precision peptide therapies for endocrine and metabolic disorders, set the price for 11,108,055 shares of its common stock at $18.00 per share, with gross proceeds…

  • Vor Biopharma Shares Slide Following Warrant Registration Filing

    Vor Biopharma Shares Slide Following Warrant Registration Filing

    Vor Biopharma Inc (NASDAQ:VOR) saw its stock decline 3.4% in premarket trading Thursday after the company filed a preliminary prospectus for the potential resale of up to 50,999,999 shares of its common stock by existing stockholders. The shares would be issued through the exercise of outstanding warrants, including 16 million shares allocated to a subsidiary…

  • CoreWeave Secures New Multi-Billion Dollar Contract with OpenAI

    CoreWeave Secures New Multi-Billion Dollar Contract with OpenAI

    CoreWeave Inc (NASDAQ:CRWV) announced Thursday that it has signed an expanded agreement with OpenAI valued at up to $6.5 billion, solidifying its role as a key infrastructure provider for high-performance artificial intelligence workloads. With this addition, CoreWeave’s cumulative deal value with OpenAI now totals approximately $22.4 billion, up from the prior $15.9 billion commitment. This…

  • DarioHealth Shares Soar 39% as Company Weighs Strategic Alternatives

    DarioHealth Shares Soar 39% as Company Weighs Strategic Alternatives

    DarioHealth (NASDAQ:DRIO) experienced a 38.7% surge in early trading in New York on Thursday after the digital health company announced it is exploring strategic options following multiple unsolicited expressions of interest. The company has established a special board committee to assess potential opportunities and has retained Perella Weinberg as its financial adviser to guide the…

  • LuxExperience Shares Surge 59% After Strong Mytheresa Growth and YNAP Acquisition

    LuxExperience Shares Surge 59% After Strong Mytheresa Growth and YNAP Acquisition

    LuxExperience B.V. (NYSE:LUXE) saw its stock jump 59.12% in pre-market trading Thursday after reporting impressive fourth-quarter results, driven by robust performance at its Mytheresa business and the recent YOOX NET-A-PORTER (YNAP) acquisition. The luxury multi-brand digital platform posted Q4 net sales of €587.8 million, with Mytheresa delivering €248.9 million, up 11.5% year-over-year from €223.2 million…

  • CarMax Shares Drop After Q2 Earnings Fall Short of Expectations

    CarMax Shares Drop After Q2 Earnings Fall Short of Expectations

    CarMax, Inc. (NYSE:KMX) shares declined 7.2% after the used car retailer reported second-quarter earnings that fell well below analyst forecasts, as both revenue and profit were hit by tough market conditions. The company posted EPS of $0.64 for the quarter ending August 31, 2025, far below the expected $1.04 per share. Total revenue came in…

  • PepGen Shares Skyrocket After Record DM1 Splicing Correction Results

    PepGen Shares Skyrocket After Record DM1 Splicing Correction Results

    PepGen Inc. (NASDAQ:PEPG) shares surged 145% following the biotech firm’s announcement of unprecedented splicing correction in patients with myotonic dystrophy type 1 (DM1) from its FREEDOM-DM1 Phase 1 study. The company reported a mean splicing correction of 53.7% after a single 15 mg/kg dose of its PGN-EDODM1 therapy—substantially higher than any previously documented results in…